Latest XVIVO News & Updates

See the latest news and media coverage for XVIVO. We track all announcements, press releases, and industry mentions in real time, all in one place.

XVIVO

Organ perfusion technologies provider

xvivogroup.com

Headquarters: Mölndal, Sweden
Founded year: 1998
Company type: Public company
Number of employees: 50–300
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about XVIVO

In short: XVIVO secured CE certificates for its heart preservation technology and expanded patient enrollment for its US clinical trials.

Company announcements

August 11 XVIVO

XVIVO receives CE certificates for its heart preservation technology

The XVIVO Heart Assist Transport system uses HOPE to extend preservation time, reducing severe complications by 38% and improving survival rates.

August 3 XVIVO

XVIVO granted additional patient enrollment in PRESERVE CAP study

FDA approval enables continued enrollment in CAP study of 60 heart transplantations using XVIVO Heart Assist Transport, with CMS cost recovery support.

July 14 XVIVO

XVIVO's net sales grew 34 percent in Q2

EBITDA margin improved to 19 percent, cash flow from operations was SEK 63.5 million.

May 18 XVIVO

XVIVO's heart technology gets regulatory derogation and reimbursement in France

The derogation enabled 11 heart transplants at Hôpital La Pitié-Salpêtrière. Reimbursement now allows broad national use.

Media coverage

August 10 Dagens industri

Bure-owned company surges after 'regulatory milestone'

Bure-owned transplantation company Xvivo Perfusion surges on the stock exchange after the company received CE certification for its heart-preserving technology. The system is...

August 2 Yahoo Finance

XVIVO Granted Additional Patient Enrollment in the US PRESERVE CAP Study for XVIVO Heart Assist Transport

GOTHENBURG, SE / ACCESS Newswire / August 3, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - XVIVO announces that the US Food and Drug Administration (FDA...

August 2 ZoneBourse

Xvivo Perfusion gets the green light to include more patients in its cardiac study in the United States

The medical technology company Xvivo Perfusion has received authorization from the Food and Drug Administration to include 60 additional patients in the American CAP study for...

July 30 Digital Health

NICE backs lung preservation machine for NHS use

A specialist machine designed to keep donated lungs functioning outside the body has been conditionally recommended by NICE.

Never miss news about XVIVO

Track XVIVO and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.